Oncoclinicas do Brasil (ONCO3) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.91x

Oncoclinicas do Brasil (ONCO3) has a Cash Flow Reinvestment Rate of 0.91x as of September 2025, reinvesting R$138.30 Million (capex R$52.99 Million plus investments R$-85.31 Million) from operating cash flow of R$151.75 Million. See cash generation quality of Oncoclinicas do Brasil to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.91x
(Capex + Investments) / Operating CF

Total Reinvested

R$138.30 Million
Capex + Investments

Operating Cash Flow

R$151.75 Million
BRL

Capital Expenditures

R$52.99 Million
BRL

Oncoclinicas do Brasil Cash Flow Reinvestment Rate (2013–2020)

Historical reinvestment intensity for Oncoclinicas do Brasil across 6 annual periods. For the full cash flow conversion analysis, see Oncoclinicas do Brasil cash conversion from operations.

Annual Cash Flow Reinvestment Rate for Oncoclinicas do Brasil (2013–2020)

Year-by-year capital reinvestment analysis for Oncoclinicas do Brasil. See ONCO3 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (BRL) Operating CF Capex YoY Change
2020 2.76x R$268.98 Million R$97.56 Million R$204.80 Million ▲ +35.4%
2019 2.04x R$197.73 Million R$97.08 Million R$190.19 Million ▼ -67.0%
2018 6.17x R$239.70 Million R$38.86 Million R$238.45 Million ▲ +2225.0%
2017 0.27x R$35.89 Million R$135.26 Million R$34.64 Million ▼ -83.1%
2014 1.57x R$14.57 Million R$9.29 Million R$14.57 Million ▼ -30.5%
2013 2.26x R$16.58 Million R$7.34 Million R$16.58 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow